Skip to content

Viatris VTRS EV / sales

EV / sales at other companies

Pfizer logo
PfizerPFE
3.5×+0.3×
McKesson logo
McKessonMCK
0.3×0.0×
Cencora logo
CencoraCOR
0.2×0.0×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
5.5×0.0×
Roivant Sciences logo
Roivant SciencesROIV
2,241.3×+1,993×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.4×

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$17.9B+49.6%
Enterprise value$30.71B+17.7%
P/S1.2×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Calculated from Viatris’s reported figures.

Based on the most recent quarter.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's EV / sales?
Viatris (VTRS) reported EV / sales of 1.9× in Q1 2026.
How has Viatris's EV / sales changed year-over-year?
Viatris's EV / sales increased by 15.8% year-over-year, from 1.7× to 1.9×.
What is the long-term trend for Viatris's EV / sales?
Over 4 years (2021 to 2025), Viatris's EV / sales has grown at a -7.0% compound annual growth rate (CAGR), from 9.6× to 7.2×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.